<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03841643</url>
  </required_header>
  <id_info>
    <org_study_id>2146</org_study_id>
    <nct_id>NCT03841643</nct_id>
  </id_info>
  <brief_title>Comparison of Calcium Phosphate Cement With Patient-specific Implants for Cranial Reconstruction</brief_title>
  <acronym>CRAN-PSI</acronym>
  <official_title>Comparison of Calcium Phosphate Cement With Patient-specific Implants for Cranial Reconstruction: a Randomized-controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AZ Sint-Jan AV</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AZ Sint-Jan AV</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background Cranial reconstruction after monocortical bonegraft harvesting remains a clinical&#xD;
      challenge for the maxillofacial surgeon. At present, there is no gold standard technique&#xD;
      advised. Patient-specific implants are gaining terrain in the field of craniofacial&#xD;
      reconstruction. Comparative studies on differences in success rates between different&#xD;
      biomaterials for application in craniofacial surgery are lacking.&#xD;
&#xD;
      Aims The primary objective is to evaluate, in terms of cosmetic result, the postoperative&#xD;
      successful outcome of patient-standardized implants for cranial reconstruction after&#xD;
      bonegraft harvesting for jaw augmentation of patients with severely atrophic jaw.&#xD;
&#xD;
      Design Patients considered eligible for cranial bone-augmentation of the severely atrophic&#xD;
      jaw, that provide their consent for participation in the trial, will be randomized at&#xD;
      recruitment into either the patient-specific implant (P) or cement (C) group. In the P group,&#xD;
      the cranial bone defect will be reconstructed with a patient-specific implant (KLS Martin,&#xD;
      Tuttlingen, Germany). In the C group, the cranial bone defect will be reconstructed with&#xD;
      HydrosetTM (Stryker, New Jersey, USA), calcium phosphate cement, according to the current&#xD;
      standard practice at the department.&#xD;
&#xD;
      Parameters representing ease of application of the biomaterial , postoperative complication&#xD;
      rate, cosmetic and functional outcome will be measured at fixed time-points during surgery&#xD;
      and postoperative follow-up. A cone-beam computed tomography (CBCT) scan of both the donor&#xD;
      (cranium) and receptor site (jaw) will be taken preoperatively, within 10 days postop, and 6&#xD;
      months post-operatively to measure biomaterial positioning.&#xD;
&#xD;
      Conclusions Systematic reviews demonstrate the need for randomized prospective studies&#xD;
      regarding implantable biomaterials used in facial reconstructive surgery. We hypothesize that&#xD;
      patient-specific implants provide more user-friendly alternatives to the standard care, with&#xD;
      better cosmetic results.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 21, 2017</start_date>
  <completion_date type="Actual">December 31, 2018</completion_date>
  <primary_completion_date type="Actual">August 1, 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
    <masking_description>single-blind</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>volumetric measurement of cranial defect, through superimposition of the preoperative and postoperative cone beam computed tomography</measure>
    <time_frame>within 10 days postoperative</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>ease of application of both biomaterials, as graded with a 0 to 10 VAS score by the treating physician</measure>
    <time_frame>perioperative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ease of application of both biomaterials, as determined by surgical time required</measure>
    <time_frame>perioperative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative complications, as graded by CTCAE 4.0 by the treating surgeon</measure>
    <time_frame>within 30 days postoperative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>patient satisfaction, as graded with a 0 to 10 VAS score</measure>
    <time_frame>within 30 days postop</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative complications, as graded by CTCAE 4.0 by the treating surgeon</measure>
    <time_frame>at 6 months postop</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>patient satisfaction, as graded with a 0 to 10 VAS score</measure>
    <time_frame>at 6 months postop</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>final implant position, as determined with CBCT</measure>
    <time_frame>at 6 months postop</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Cranial Defect</condition>
  <arm_group>
    <arm_group_label>C group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In the C group, the cranial bone defect will be reconstructed with HydrosetTM (Stryker, New Jersey, USA), calcium phosphate cement, according to the current standard practice at the department.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>P group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In the P group, the cranial bone defect will be reconstructed with a patient-specific implant (KLS Martin, Tuttlingen, Germany).</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>patient-specific implant</intervention_name>
    <description>solid titanium implant that functions as a guiding template for harvesting, and as an implant for reconstruction of the cranial defect</description>
    <arm_group_label>P group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>cement</intervention_name>
    <description>norian cement for reconstruction of the cranial defect</description>
    <arm_group_label>C group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients aged 18 years or older&#xD;
&#xD;
          -  patients of all genders&#xD;
&#xD;
          -  patients with moderate to extreme bone atrophy of the jaw, caused by periodontitis or&#xD;
             edentulism&#xD;
&#xD;
          -  patients requiring a full reconstruction (both anterior and posterior region)&#xD;
&#xD;
          -  patients receiving their surgery and follow-up care at the AZ Sint-Jan Brugge-Oostende&#xD;
             AV&#xD;
&#xD;
          -  patients providing written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  - Patients not eligible according to abovementioned criteria&#xD;
&#xD;
          -  Patients with severe uncontrolled diabetes&#xD;
&#xD;
          -  Patients with contraindications for general anesthesia&#xD;
&#xD;
          -  Patients with known allergies to the biomaterials used&#xD;
&#xD;
          -  Patients with cranial vault without diploe and/or cranial vault thickness &lt;3mm, as&#xD;
             defined with cone-beam CT&#xD;
&#xD;
          -  Patients with previous surgery of the skull region&#xD;
&#xD;
          -  Patients with an explicit risk of bleeding from cranial venous structures, as&#xD;
             described by the radiologist based on his/her evaluation of the preoperative CBCT&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nathalie Neyt, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>maxillofacial department, AZ Sint-Jan Brugge-Oostende AV</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department MKA, AZ Sint-Jan Brugge-Oostende AV</name>
      <address>
        <city>Brugge</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>February 13, 2019</study_first_submitted>
  <study_first_submitted_qc>February 13, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 15, 2019</study_first_posted>
  <last_update_submitted>June 18, 2019</last_update_submitted>
  <last_update_submitted_qc>June 18, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 19, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>AZ Sint-Jan AV</investigator_affiliation>
    <investigator_full_name>Nathalie Neyt</investigator_full_name>
    <investigator_title>maxillofacial surgeon, principal investigator</investigator_title>
  </responsible_party>
  <keyword>cranial reconstruction</keyword>
  <keyword>cement</keyword>
  <keyword>patient-specific implant</keyword>
  <keyword>preprothetic surgery</keyword>
  <keyword>atrophic jaw</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

